StreetAlpha.app
Home › Stocks › CARL

Carlsmed, Inc. (CARL)

Healthcare
$17.42
▲ +1.16%
LAST CLOSE · NOV 20

Carlsmed makes personalized spine fusion surgical plans, custom implants and surgical instruments for hospitals and surgical centers. It last closed at $17.42 on Nov 20, up 1.16% on the day. The next earnings report for CARL is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, CARL reported EPS of -$0.45 on revenue of $21.6M, with revenue up 64.9% from a year ago. Over its last 7 reports the stock moved an average of 12.2% the session after earnings. Over the last 12 months CARL insiders bought $0 of stock on the open market and sold $2.7M, according to SEC Form 4 filings.

AI Auto Pilots
Is CARL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CARL.

Key Stats

Last 12 months
Results
Revenue
$71.8M
+60.4% vs a year ago
Net income
−$40.1M
−55.8% margin
EPS (diluted)
−$1.13
Free cash flow
−$34.9M
−48.6% margin
Valuation
Market cap
$477.4M
27.4M shares
P/E
–
No P/E while losing money
Price to sales
6.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$35.9M
At Sep 30
Debt
$15.4M
At Sep 30
Shareholder equity
$75.7M
Shares outstanding
27.4M
At Nov 6
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: $27.2M$27.2MFY2024FY2025: $50.5M$50.5MFY2025

From CARL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
-$0.45
Quarter ended Sep 2026
Year ago EPS
-$0.40
Same quarter last year
Revenue
$21.6M
+64.9% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$1.14Dec '24Mar 2025: -$1.47Mar '25Jun 2025: -$1.47Jun '25Sep 2025: -$0.40Sep '25Dec 2025: $0.03Dec '25Mar 2026: -$0.32Mar '26Jun 2026: -$0.39Jun '26Sep 2026: -$0.45Sep '26Latest -$0.45
Revenue by quarter
Dec 2024: $9.4MDec '24Mar 2025: $10.2MMar '25Jun 2025: $12.1MJun '25Sep 2025: $13.1MSep '25Dec 2025: $15.2MDec '25Mar 2026: $16.1MMar '26Jun 2026: $18.9MJun '26Sep 2026: $21.6MSep '26Latest $21.6M
How CARL moved after its last 7 reports
Average move the session after a report ±12.2%
Nov 10, 2026After the close+26.4%
Aug 5, 2026After the close+1.0%
May 5, 2026After the close+10.3%
Feb 25, 2026After the close+15.9%
Jan 12, 2026Time not announced+13.8%
Nov 6, 2025After the close+14.9%
Aug 28, 2025After the close−2.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CARLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on CARL
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on CARL

Technical Analysis

CARL · as of the Nov 20 close · updated each morning
Uptrend

The stock is 7% above its 20 day and 13% above its 50 day average. It is 27% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 58). The nearest support is the Pivot S1 at $16.80, and the nearest resistance the Pivot at $17.53.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 7.4%/day
Key levels
$19.1552 week high+9.9%
$19.15Swing high (Nov 11)+9.9%
$18.14Pivot R1+4.1%
$17.53Pivot+0.6%
$17.42Last close
$16.80Pivot S1−3.6%
$16.1320 day average−7.4%
$15.2050 day average−12.7%
$14.72Swing low (Sep 11)−15.5%
$14.43100 day average−17.2%
$12.68200 day average−27.2%
$8.5052 week low−51.2%
Indicators
RSI (14)57.92Middle of its rangeNeutral
MACD0.74Above its signal lineBullish
Stochastic64.7Middle of its rangeNeutral
ADX (14)28.7Trending up
Williams %R-33.7Oversold below −80, overbought above −20Neutral
CCI (20)81.8Oversold below −100, overbought above 100Neutral
Rate of change+20.0%Change over 10 sessionsBullish
ATR (14)$1.30Typical daily range, 7.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for CARL

What happened before

See how CARL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for CARLHow many large options trades hit CARL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

CARL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲57 buying vs 27 selling
  • ▲Held by funds +2.2 pts
  • ▲Funds holding +13
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding8875+17.3%
In funds' top 1000–
Held by funds23.1%20.9%+2.2 pts
New / increased18 / 3922 / 33+3.6%
Reduced / sold out22 / 512 / 13+8.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CARL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CARL Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$2.7M5 sales · 2 insiders
1% of the selling was under pre-arranged trading plans.
2026-03 sold $2.6M2026-09 sold $3K2026-10 sold $15K2026-11 sold $11KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 3Jeffrey BertoliniCOOSale plan747$15.15$11K
Oct 30Jeffrey BertoliniCOOSale plan243$15.80$4K
Oct 5Jeffrey BertoliniCOOSale plan747$14.39$11K
Sep 30Jeffrey BertoliniCOOSale plan243$13.99$3K
Mar 2Michael CordonnierCEO, PresidentSale197,855$13.29$2.6M
Jul 24, 2025Philip M YoungDirectorBuy59,999$15.00$900K
Every insider buy and sale for CARL over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CARL insider trades →

From SEC Form 4 filings by CARL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CARL is in one of them and how their past CARL trades turned out.

CARL in the AI portfolios
Loading…

CARL News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CARL in an article yet. Here's the latest on the wider market.

CARL in the news

About Carlsmed

Carlsmed is a medical technology company based in Carlsbad, California. Its aprevo Technology Platform uses software and AI algorithms to create personalized surgical plans for spine fusion surgery. The platform includes custom fit spinal implants and surgical instruments for lumbar and cervical procedures. The products are sold to hospitals and ambulatory surgical centers through a direct sales team and independent sales agents, and the platform is marketed to surgeons.

Headquarters
Carlsbad, CA